Poster, Podium & Video Sessions
Presentation Authors: Suraj Parikh*, Alex E. Ward, John L. Phillips, MD, Majid A. Eshghi, MD, Sean A. Fullerton, MD, Gerald J. Matthews, MD, Michael Stern, MD, Muhammad S. Choudhury, MD, Valhalla, NY
Introduction: Readmission within 30 days of discharge following an in-patient admission is increasingly used as a quality metric. Moreover, the Patient Protection and Affordable Care Act (ACA) has associated surgical outcome and hospital readmission rates with potential reimbursement models. Currently, reported 30 day readmission rates to urology services are largely based on pooled national databases from a wide variety of patient populations and health care settings. We wished to determine a 30 day readmission to the urology service of a tertiary care hospital with high 6 year average case mix index (CMI) of 1.5.
Methods: We reviewed all readmissions within 30 days for any cause following discharge from our adult urology service between January 2010 and December 2015. We also reviewed all readmissions, demographics, and variables following 10 major urology procedures. Non-parametric univariate and regression analysis was considered with an alpha set at 0.05.
Results: We found that our 30 day un-planned readmission rate was stable (β=0.2) over a 6 year period with an overall rate of 5.22% (range 3.46-6.76). Excluding cystoprostatectomy which had the highest 30 day readmission rate of 21%, the readmission rate for the remaining 9 index procedures was 2.2% (see table). Readmission was associated with patient age, number of ICD-10 diagnoses, and no medical follow up within 1 week after discharge (P<0.05).
Conclusions: Our data provides a 30 day readmission rate for 10 index procedures at a major tertiary care urology service with a complex patient population. Planned follow up with urologic evaluation as an outpatient within 1 week after elective discharge may improve readmission rates.
Source Of Funding: None
New York Medical College
Suraj Parikh is a second year medical student at New York Medical College. He has a strong interest in urology that is growing with each of his experiences. This past year, he was awarded the Ferdinand C. Valentine Medical Student Research Grant in Urology by the New York Academy of Medicine, which he used to study the renoprotective mechanism of antixodiants in oxidative renal cell injury. His current research goals are to improve hospital quality of care by focusing on reducing readmissions.